Amplifica closed an oversubscribed $26 million Series B to advance clinical development of its injectable hair-growth pipeline.
- Amount
- $26M
- Stage
- Series B
- Announced
- 12 August 2026
- Lead
- Tasso Partners, LLC
- Other investors
- Eli Lilly and Company, principals of Scopia Capital Management, LP
- Use of funds
- Advance clinical development of novel pipeline candidates
- Checked
- Announced by the company